Ro vs Found Weight Loss 2026: GLP-1 Programs Compared
Ro vs Found for GLP-1 weight loss in 2026, compare pricing, medications, provider experience, and clinical results. See how both stack up against Trimi's $99/mo annual-plan semaglutide.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. We compare competitor programs to help patients make informed weight loss decisions.
Quick links: Semaglutide treatment, Ro semaglutide review, and Found semaglutide review.
More on GLP-1 Provider Comparisons
Ro vs Found: What You Need to Know
If you are comparing Ro vs Found for weight loss, you are evaluating two of the largest telehealth platforms offering GLP-1 receptor agonist medications in 2026. They now take different routes to the medication: Ro's current menu lists FDA-approved brand-name GLP-1s billed separately from its membership, while Found prescribes compounded semaglutide and tirzepatide with the medication included in its plan price. Ro positions itself as a pharmacy-backed platform with insurance help, while Found emphasizes a holistic approach that combines medication with behavioral coaching and community support.
Definition: Ro (formerly Roman) and Found are telehealth platforms that prescribe GLP-1 receptor agonist medications for weight management: FDA-approved brand-name products at Ro, compounded semaglutide and tirzepatide at Found. GLP-1 receptor agonists work by mimicking the incretin hormone GLP-1, which reduces appetite, slows gastric emptying, and promotes satiety. Clinical trials have demonstrated 14.9% to 22.5% body weight reduction with these medications when combined with lifestyle modifications.
Ro (Ro Body) is one of the largest direct-to-consumer telehealth companies in the United States. Its weight loss program uses an affiliated pharmacy, Roman Health Pharmacy, alongside partner pharmacies. The Ro Body membership includes unlimited provider messaging, side effect and titration support, 1:1 health coaching, and an insurance concierge that checks coverage and handles prior authorization for select brand-name medications. Medication is billed separately from the membership.
Found takes a different approach, branding itself as a comprehensive weight care platform. Found combines GLP-1 prescriptions with one-on-one behavioral coaching, community forums, and personalized treatment plans built around the premise that medication alone is insufficient for sustained weight loss. Their model attracts patients who want structured accountability and lifestyle support alongside their prescription.
Both platforms deliver legitimate GLP-1 treatment. The question is whether the differences in pricing and support justify choosing one over the other, and whether either offers better value than Trimi at $99 per month for compounded semaglutide.
Side-by-Side: Ro vs Found vs Trimi
The following table compares key features across all three platforms to help you evaluate which program best fits your needs and budget for GLP-1 weight loss treatment.
| Feature | Ro | Found | Trimi |
|---|---|---|---|
| Compounded Semaglutide | No (brand-name GLP-1s on current menu) | Yes | Yes |
| Compounded Tirzepatide | No (brand-name GLP-1s on current menu) | Yes | Yes |
| Behavioral Coaching | 1:1 health coaching listed | Yes (included) | Provider guidance |
| Community Support | No | Yes | No |
| Provider Communication | Unlimited provider messaging | Messaging + coaching | Messaging + video |
| Pharmacy Model | Affiliated Roman Health Pharmacy + partner pharmacies | Partner compounding pharmacies | Partner 503A community sterile-compounding pharmacy |
| Shipping | Ships within a week once prescribed | Free shipping | Free overnight once compounded (typically 2-4 days from signup) |
| Plan Terms | Monthly membership or prepaid 3, 6, or 12-month plans | Month to month, or 3, 6, or 12-month plans | Annual plan is a 12-month commitment; monthly plan available |
| Consultation Fee | Included in membership | Included | Free |
| Insurance | Membership is cash-pay; insurance concierge for select brand-name medications | Insurance track (medication included, visit copay) | No (cash-pay) |
Pricing Comparison: Ro vs Found vs Trimi
Cost is the most frequently cited factor when patients compare GLP-1 providers. Because these medications are used long-term, often 12 months or longer, even modest monthly differences compound into significant savings over time. Here is how Ro, Found, and Trimi's pricing compare in 2026.
| Cost Factor | Ro | Found | Trimi |
|---|---|---|---|
| Semaglutide | Brand-name only; medication billed separately | $169 - $289 per 28 days (cash) | From $99/mo (annual plan) |
| Tirzepatide | Brand-name only; medication billed separately | $239 - $359 per 28 days (cash) | From $125/mo (annual plan) |
| Membership Fee | $39 first month, then $149/mo (or $74/mo prepaid annually) | None (included in plan price) | None |
| Coaching Included | 1:1 health coaching listed | Yes | Provider support |
| Lowest Rate Requires | 12-month prepaid membership | 12-month plan paid up front | Annual plan (12-month commitment) |
| 6-Month Total (Sema) | Membership only; medication extra | $1,314 (6-month cash plan, six cycles) | $720 (6-month plan) |
| 12-Month Total (Sema) | Membership only; medication extra | $2,028 or more (12-month cash plan) | $1,188 (annual plan) |
| 6-Month Total (Tirz) | Membership only; medication extra | $1,734 (6-month cash plan, six cycles) | $1,050 (6-month plan) |
| 12-Month Total (Tirz) | Membership only; medication extra | $2,868 or more (12-month cash plan) | $1,500 (annual plan) |
Ro's membership covers care, not medication, so its total depends on which brand-name medication is prescribed and whether insurance covers it. Found's cash-pay price includes compounded medication: on 12-month plans, $169 per 28-day cycle for semaglutide and $239 for tirzepatide, at least $70 and $114 more per billing period than Trimi's annual-plan rates. Over 12 months of tirzepatide on those terms, Trimi's annual plan costs at least $1,368 less than Found's. These are meaningful differences when treatment typically continues for a year or longer.
Price note: Telehealth GLP-1 pricing changes frequently. Found figures come from its plans and store pages, checked 29 September 2026, and Found bills per 28-day cycle. Ro figures come from its published pricing and weight-loss pages. Promotional pricing and plan changes may affect actual costs. Always confirm current pricing directly with each provider.
Medication Options: Semaglutide and Tirzepatide
The medications prescribed by Ro and Found are now different in kind. Found offers compounded semaglutide and compounded tirzepatide. Ro's current menu lists FDA-approved brand-name GLP-1s, in injection and pill form, and its terms say compounded medication may be prescribed only during national drug shortages.
| Medication Detail | Ro | Found | Trimi |
|---|---|---|---|
| Compounded Semaglutide | No (not on current menu) | Yes | Yes |
| Compounded Tirzepatide | No (not on current menu) | Yes | Yes |
| Pharmacy Type | Affiliated pharmacy + partners | Partner pharmacies | Partner 503A |
| Dose Titration Protocol | Provider-guided, standard | Coach + provider guided | Provider-guided |
| Oral GLP-1 Options | Yes (brand-name pills) | Some plans | Injectable focus |
| B12/Levocarnitine Add-ons | No (brand-name products) | Limited | Available |
Semaglutide is a GLP-1 receptor agonist originally developed by Novo Nordisk and approved by the FDA under the brand names Ozempic (for type 2 diabetes) and Wegovy (for weight management). Compounded semaglutide follows a separate pathway: it is prepared by 503A compounding pharmacies against an individual prescription under state pharmacy board oversight, and is not FDA-approved as a drug.
Tirzepatide is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly, approved as Mounjaro (diabetes) and Zepbound (weight management). It acts on both the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, which clinical trials suggest may produce greater weight loss than semaglutide alone. Found offers compounded tirzepatide at a higher price than its semaglutide; Ro offers the brand-name product.
Provider Experience and Support
The treatment experience differs between Ro and Found in ways that matter to different types of patients. Understanding these differences helps you choose the platform that aligns with your preferences and support needs.
Where Ro Wins Over Found
Affiliated pharmacy, Roman Health Pharmacy, alongside partner pharmacies
Insurance concierge that checks coverage and handles prior authorization for select brand-name medications
Access to FDA-approved brand-name GLP-1s, including pill options
Lower membership fee on an annual prepaid plan ($74 a month) for patients whose insurance covers the medication
Established multi-category telehealth platform
No pressure to engage with coaching or community features, straightforward medication access
For a deeper look at Ro's approach, read our Ro semaglutide review and our guide on Ro weight loss side effects.
Where Found Wins Over Ro
Dedicated behavioral coaching included with medication, structured support for habit change and accountability
Community features connect patients on similar journeys for motivation and shared experience
Compounded medication included in one plan price, with no separate pharmacy bill
Emphasis on long-term behavioral change, not just pharmacological intervention but sustainable lifestyle modification
Broader medication toolkit historically, including non-GLP-1 options for patients who may benefit from different approaches
Insurance track that still includes the compounded medication in the plan price
For more on Found's program, see our Found semaglutide review and Found weight loss side effects guide.
Where Both Fall Short
Neither offers compounded medication at Trimi's annual-plan rates of $99/mo for semaglutide and $125/mo for tirzepatide
Neither platform's higher pricing has been shown to produce better clinical outcomes than lower-cost providers
Both platforms bundle services into the price that not every patient needs or actively uses
Ro's membership fee is billed on top of medication and is non-refundable once paid
Found's lowest rates require a 12-month plan paid up front
Clinical Evidence Behind GLP-1 Weight Loss
The clinical evidence for semaglutide and tirzepatide comes from large trials of the FDA-approved products. Understanding that trial data helps you set realistic expectations for your weight loss journey.
Semaglutide: STEP 1 Trial Results
The landmark STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) established semaglutide 2.4 mg as a highly effective weight loss medication. In this 68-week, double-blind, randomized controlled trial involving 1,961 adults with obesity or overweight with at least one weight-related comorbidity, participants receiving semaglutide achieved a mean body weight reduction of 14.9% compared to 2.4% in the placebo group. Approximately one-third of participants lost 20% or more of their body weight, a threshold previously achievable only through bariatric surgery.
The most common side effects in the STEP 1 trial were gastrointestinal: nausea (44.2%), diarrhea (31.5%), vomiting (24.8%), and constipation (23.4%). Most gastrointestinal events were mild to moderate in severity and occurred primarily during dose escalation. These side effects are relevant whether you receive semaglutide through Ro, Found, or any other provider, the medication profile does not change based on the prescribing platform.
Tirzepatide: SURMOUNT-1 Trial Results
The SURMOUNT-1 trial (Jastreboff et al., New England Journal of Medicine, 2022) demonstrated that tirzepatide produced even greater weight loss than semaglutide in head-to-head comparisons. In this 72-week trial involving 2,539 adults with obesity, participants receiving the highest dose of tirzepatide (15 mg) achieved a mean body weight reduction of 22.5%. The 10 mg dose produced 21.4% mean weight loss, and the 5 mg dose produced 16.0%, all significantly exceeding placebo at 3.1%.
These results explain why tirzepatide has gained significant patient interest and why both Ro and Found now offer it alongside semaglutide, as a brand-name product at Ro and a compounded preparation at Found. At Trimi, compounded tirzepatide is $125 per month on the annual plan, compared with $239 to $359 per 28-day cycle at Found on cash pay.
What the Evidence Means for Platform Choice
Clinical trial outcomes depend on the medication and patient adherence, not on which telehealth platform prescribes the medication. A patient receiving compounded semaglutide through Trimi at $99 per month on the annual plan receives the same active pharmaceutical ingredient as a patient paying $169 to $289 per 28-day cycle through Found. The clinical evidence does not differentiate by provider. What the evidence does suggest is that long-term adherence matters enormously, and affordability is a primary driver of whether patients can sustain treatment long enough to achieve meaningful results.
Key statistic: The STEP 1 trial showed 14.9% mean body weight loss with semaglutide 2.4 mg over 68 weeks (Wilding et al., 2021). The SURMOUNT-1 trial showed 22.5% mean body weight loss with tirzepatide 15 mg over 72 weeks (Jastreboff et al., 2022). Both trials studied the FDA-approved products; the compounded preparations dispensed through Found and Trimi have not been studied in trials of their own.
Who Should Choose Which Provider?
Choose Ro If
You want an FDA-approved brand-name GLP-1 and help getting it covered by commercial insurance, from an established telehealth platform with an affiliated pharmacy. You are comfortable paying a membership ($149 a month, or as low as $74 a month prepaid annually) on top of the medication cost. Read more in our full Ro review.
Choose Found If
You value dedicated behavioral coaching alongside your medication and believe structured accountability will improve your long-term outcomes. You want community support from other patients on similar journeys. You are willing to pay a premium for a holistic weight management program that goes beyond medication alone. See our full Found review.
Choose Trimi If
You want the most affordable access to compounded semaglutide at $99 per month or tirzepatide at $125 per month on the annual plan (a 12-month commitment), with competent provider oversight, no membership fee, and no hidden fees. You recognize that the medication itself, not the platform's extras, is the primary driver of weight loss results. You want to maximize your chances of sustaining treatment long-term by minimizing cost.
The Bottom Line: Ro vs Found for Weight Loss
Ro and Found both deliver legitimate GLP-1 weight loss treatment through well-established telehealth platforms. Ro offers brand-name medication with insurance help and an affiliated pharmacy, with the medication billed separately from its membership. Found offers more comprehensive behavioral support with coaching and community features. Both approaches have produced positive patient outcomes.
For compounded medication, neither matches Trimi's pricing: $99 per month for compounded semaglutide and $125 per month for tirzepatide on the annual plan (a 12-month commitment), with consultations, free shipping, and no membership fee. What drives results is the treatment you stay on, not the platform wrapping around it. For most patients, choosing the provider that makes long-term treatment most financially sustainable is the best decision they can make.
Whether you are leaning toward Ro's streamlined approach or Found's coaching-intensive model, we recommend also exploring the cheapest GLP-1 options available in 2026 before committing. The savings over 12 months can be substantial, and those savings make it easier to stay on treatment long enough to reach your goals.
Frequently Asked Questions
Is Ro or Found better for GLP-1 weight loss?
Both offer GLP-1 weight loss programs through telehealth, but with different medications. Ro Body prescribes FDA-approved brand-name GLP-1s and charges a membership ($39 for the first month, then $149 a month, or as low as $74 a month prepaid annually), with the medication billed separately through insurance or cash pay. Found prescribes compounded semaglutide and tirzepatide with the medication included in one price per 28-day cycle ($169 to $289 for semaglutide on cash pay, or from $99 on its insurance track plus visit copays). Neither is objectively better; it depends on whether you want insurance help with a brand-name medication or compounded medication in one price. Trimi offers compounded semaglutide at $99 per month on its annual plan (a 12-month commitment) with provider support and no membership fee.
How much does Ro cost compared to Found for semaglutide?
Ro Body charges a membership of $39 for the first month, then $149 a month on a monthly plan or as low as $74 a month on a 12-month prepaid plan, and bills medication separately; Ro's current menu lists FDA-approved brand-name medications, not compounded semaglutide. Found charges one price per 28-day cycle that includes compounded medication: $169 to $289 for semaglutide and $239 to $359 for tirzepatide on cash pay, or less on its insurance track plus visit copays. On a 12-month cash plan, Found's semaglutide costs $2,028 or more. Trimi's annual plan costs $1,188 for semaglutide ($99 a month) or $1,500 for tirzepatide ($125 a month), with the compounded medication included.
Does Found include coaching that Ro does not?
Both include some coaching. Found builds behavioral coaching, habit guidance, and an AI companion into its plan price. Ro lists unlimited provider messaging and 1:1 health coaching as part of the Ro Body membership. Whether coaching justifies the price difference depends on your needs; many patients achieve strong results with medication and standard provider guidance alone, without paying extra for structured coaching programs.
Which platform prescribes better GLP-1 medications?
They prescribe different kinds of medication. Ro's current menu lists FDA-approved brand-name GLP-1s, in injection and pill form, and its terms say compounded medication may be prescribed only during national drug shortages. Found prescribes compounded semaglutide and tirzepatide, which are prepared by state-licensed pharmacies against an individual prescription and are not FDA-approved as drugs. Trimi also prescribes compounded semaglutide and tirzepatide.
Can I switch from Ro to Found or from Found to Ro?
Yes. Ro offers a monthly membership as well as prepaid 3, 6, and 12-month plans, asks for cancellation at least 48 hours before the next renewal, and says its membership fee is non-refundable once paid. Found offers month-to-month billing as well as 3, 6, and 12-month plans. You will need to complete a new medical intake with the new provider, which may cause a brief gap in treatment, and moving between a brand-name and a compounded medication is a clinical decision for your provider. Before switching, consider comparing both to Trimi at $99 per month for semaglutide or $125 per month for tirzepatide on its annual plan (a 12-month commitment).
Do Ro and Found accept insurance for GLP-1 medications?
Found does: it offers insurance plans alongside cash pay, the compounded medication is still included in the plan price, and insurance is billed for the required video visits at your copay, which Found says is typically around $30. Ro's membership is cash-pay and is not covered by insurance, but its insurance concierge checks coverage and handles prior authorization for select brand-name GLP-1 medications, which are billed separately. Trimi is cash-pay, at $99 per month for compounded semaglutide on the annual plan (a 12-month commitment).
What is cheaper than both Ro and Found for GLP-1 weight loss?
Trimi offers compounded semaglutide at $99 per month and tirzepatide at $125 per month on its annual plan (a 12-month commitment), including consultations, free shipping, and no membership fee. Over twelve months, that is at least $840 less than Found's 12-month cash plan for semaglutide and at least $1,368 less for tirzepatide. Ro's membership alone is as low as $74 a month prepaid annually before any medication, and Ro prescribes brand-name rather than compounded medication, so the two are not a like-for-like price comparison.
Sources & References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PubMed.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. PubMed.
- Ro. Weight loss pricing, how it works, and insurance pages (2026).
- Found. Plans and pricing, and compounded semaglutide and tirzepatide store pages. Accessed 29 September 2026.
- FDA guidance on drug compounding and 503A compounding pharmacies.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any weight loss medication. GLP-1 receptor agonists carry risks and are not appropriate for all patients. Trimi is a competitor to both Ro and Found, readers should be aware of our perspective when evaluating these comparisons.